Normanno N - Search Results

1

Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions.

Morabito A, Piccirillo MC, Falasconi F, De Feo G, Del Giudice A, Bryce J, Di Maio M, De Maio E, Normanno N, Perrone F. Morabito A, et al. Among authors: normanno n. Oncologist. 2009 Apr;14(4):378-90. doi: 10.1634/theoncologist.2008-0261. Epub 2009 Apr 6. Oncologist. 2009. PMID: 19349511 Free article. Review.

2

Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.

D'Antonio A, Losito S, Pignata S, Grassi M, Perrone F, De Luca A, Tambaro R, Bianco C, Gullick WJ, Johnson GR, Iaffaioli VR, Salomon DS, Normanno N. D'Antonio A, et al. Among authors: normanno n. Int J Oncol. 2002 Nov;21(5):941-8. Int J Oncol. 2002. PMID: 12370739

3

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?

Normanno N, Maiello MR, De Luca A. Normanno N, et al. J Cell Physiol. 2003 Jan;194(1):13-9. doi: 10.1002/jcp.10194. J Cell Physiol. 2003. PMID: 12447985 Review.

4

Molecular markers to predict response to gefitinib: EGFR, ErbB-2, or more?

Normanno N, Di Maio M, Perrone F, Campiglio M. Normanno N, et al. J Clin Oncol. 2004 May 15;22(10):2035-6; author reply 2036-7. doi: 10.1200/JCO.2004.99.337. J Clin Oncol. 2004. PMID: 15143103 No abstract available.

5

Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?

De Luca A, Grassii M, Maiello MR, Di Maio M, Mancino M, De Maio E, Gridelli C, Perrone F, Normanno N. De Luca A, et al. Among authors: normanno n. Anticancer Res. 2004 Sep-Oct;24(5A):2985-9. Anticancer Res. 2004. PMID: 15517905 Free article.

6

Targeted therapies and non-small cell lung cancer: methodological and conceptual challenge for clinical trials.

Perrone F, Di Maio M, Budillon A, Normanno N. Perrone F, et al. Among authors: normanno n. Curr Opin Oncol. 2005 Mar;17(2):123-9. doi: 10.1097/01.cco.0000155048.51919.eb. Curr Opin Oncol. 2005. PMID: 15725916 Review.

7

Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.

Di Maio M, Gridelli C, Normanno N, Perrone F, Ciardiello F. Di Maio M, et al. Among authors: normanno n. J Cell Physiol. 2005 Dec;205(3):355-63. doi: 10.1002/jcp.20402. J Cell Physiol. 2005. PMID: 15895392 Review.

8

Is the gefitinib plus trastuzumab combination feasible in breast cancer patients?

Normanno N, Campiglio M, Perrone F, De Luca A, Menard S. Normanno N, et al. Ann Oncol. 2005 Oct;16(10):1709. doi: 10.1093/annonc/mdi325. Epub 2005 Sep 8. Ann Oncol. 2005. PMID: 16150806 Free article. No abstract available.

9

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.

Normanno N, Di Maio M, De Maio E, De Luca A, de Matteis A, Giordano A, Perrone F; NCI-Naples Breast Cancer Group. Normanno N, et al. Endocr Relat Cancer. 2005 Dec;12(4):721-47. doi: 10.1677/erc.1.00857. Endocr Relat Cancer. 2005. PMID: 16322319 Review.

10

Epidermal growth factor receptor (EGFR) signaling in cancer.

Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS. Normanno N, et al. Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27. Gene. 2006. PMID: 16377102 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters